undefined
Posts
undefined
Followers
User since undefined NaN
FDA approves Rybrevant for advanced lung cancer
By Matthew Shinkle,
2024-09-20The FDA approved amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to the agent’s manufacturer. The indication applies to adults with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or L858R substitution mutations whose disease progressed on...
1